These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14535971)

  • 21. Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study.
    Sørensen GV; Cronin-Fenton DP; Sørensen HT; Ulrichsen SP; Pedersen L; Lash TL
    Breast Cancer Res; 2012 Feb; 14(1):R21. PubMed ID: 22305057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levothyroxine treatment and occurrence of fracture of the hip.
    Sheppard MC; Holder R; Franklyn JA
    Arch Intern Med; 2002 Feb; 162(3):338-43. PubMed ID: 11822927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study.
    Wu CS; Chang CM; Tsai YT; Huang YW; Tsai HJ
    J Clin Psychiatry; 2015 Sep; 76(9):1216-23. PubMed ID: 26115407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study.
    Floyd A; Pedersen L; Nielsen GL; Thorlacius-Ussing O; Sorensen HT
    Am J Gastroenterol; 2003 Jun; 98(6):1305-8. PubMed ID: 12818274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugs.
    Johnsen SP; Monster TB; Olsen ML; Thisted H; McLaughlin JK; Sørensen HT; Lervang HH; Rungby J
    Am J Ther; 2006; 13(2):134-40. PubMed ID: 16645430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of alpha-blockers and the risk of hip/femur fractures.
    Souverein PC; Van Staa TP; Egberts AC; De la Rosette JJ; Cooper C; Leufkens HG
    J Intern Med; 2003 Dec; 254(6):548-54. PubMed ID: 14641795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugs.
    Driessen JH; van Onzenoort HA; Starup-Linde J; Henry R; Neef C; van den Bergh J; Vestergaard P; de Vries F; Burden AM
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1017-25. PubMed ID: 26183226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton-pump inhibitor use and hip fractures in men: a population-based case-control study.
    Adams AL; Black MH; Zhang JL; Shi JM; Jacobsen SJ
    Ann Epidemiol; 2014 Apr; 24(4):286-90. PubMed ID: 24507954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced fracture risk in users of thiazide diuretics.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2005 Mar; 76(3):167-75. PubMed ID: 15719207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.
    Robertson DJ; Larsson H; Friis S; Pedersen L; Baron JA; Sørensen HT
    Gastroenterology; 2007 Sep; 133(3):755-60. PubMed ID: 17678921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers.
    Bazelier MT; de Vries F; Bentzen J; Vestergaard P; Leufkens HG; van Staa TP; Koch-Henriksen N
    Mult Scler; 2012 May; 18(5):622-7. PubMed ID: 22020418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
    de Vries F; Souverein PC; Cooper C; Leufkens HG; van Staa TP
    Calcif Tissue Int; 2007 Feb; 80(2):69-75. PubMed ID: 17308987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease.
    Johannes CB; Schneider GA; Dube TJ; Alfredson TD; Davis KJ; Walker AM
    Chest; 2005 Jan; 127(1):89-97. PubMed ID: 15653967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study.
    Torvinen-Kiiskinen S; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1135-1142. PubMed ID: 29508411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing Risk of Hospital-Treated Infections and Community-Based Antibiotic Use After Hip Fracture Surgery: A Nationwide Study 2005-2016.
    Kjørholt KE; Johnsen SP; Kristensen NR; Prieto-Alhambra D; Pedersen AB
    J Bone Miner Res; 2019 Mar; 34(3):437-446. PubMed ID: 30515887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the higher mortality among men with hip fracture explained by sex-related differences in quality of in-hospital care? A population-based cohort study.
    Kristensen PK; Johnsen SP; Mor A; Thillemann TM; Pedersen AB
    Age Ageing; 2017 Mar; 46(2):193-199. PubMed ID: 27932356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
    de Vries F; Pouwels S; Bracke M; Leufkens HG; Cooper C; Lammers JW; van Staa TP
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):612-9. PubMed ID: 16998945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.